A party’s desire to sponsor research at an institution often relates to the further development of an invention claimed in an existing “background” patent application
Even though the ‘grant of license’ clause is the primary operative clause of the licensing agreement, it is often not given due consideration in contract
Many licensing agreements have a percentage royalty that the licensee must pay the licensor on sales of licensed products. This percentage is often the primary
Continuing the topic of the “Net Sales” royalty base, this instalment relates to the important topic, especially in pharma licensing agreements, of how to deal